Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+4.73%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$54B
AUM Growth
+$1.06B
(+2%)
Cap. Flow
-$141M
Cap. Flow
% of AUM
-0.26%
Top 10 Holdings %
Top 10 Hldgs %
30.64%
Holding
972
New
111
Increased
254
Reduced
428
Closed
112
Top Buys
| 1 |
HES
Hess
HES
|
$470M |
| 2 |
Exxon Mobil
XOM
|
$248M |
| 3 |
Hubbell
HUBB
|
$139M |
| 4 |
Costco
COST
|
$124M |
| 5 |
Chubb
CB
|
$117M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
$281M |
| 2 |
Emerson Electric
EMR
|
$233M |
| 3 |
AbbVie
ABBV
|
$169M |
| 4 |
Amazon
AMZN
|
$167M |
| 5 |
RB Global
RBA
|
$165M |
Sector Composition
| 1 | Technology | 29.07% |
| 2 | Healthcare | 16.38% |
| 3 | Financials | 10.36% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Industrials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Revolution Medicines
RVMD
$7.57B
| $6.6M | 0.01% |
170,000
-30,000
| -15% | -$1.16M |
|
677
Broadridge
BR
$29.4B
| $6.58M | 0.01% |
33,400
-47,100
| -59% | -$9.28M |
|
678
Kyndryl
KD
$7.57B
| $6.58M | 0.01% |
250,000
-200,000
| -44% | -$5.26M |
|
679
Dianthus Therapeutics
DNTH
$853M
| $6.47M | 0.01% |
250,000
-48,000
| -16% | -$1.24M |
|
680
Brown & Brown
BRO
$31.3B
| $6.45M | 0.01% |
72,100
-459,600
| -86% | -$41.1M |
|
681
Vaxcyte
PCVX
$4.29B
| $6.42M | 0.01% |
85,088
| – | – |
|
682
Repligen
RGEN
$7.01B
| $6.3M | 0.01% |
50,000
-65,000
| -57% | -$8.19M |
|
683
Warrior Met Coal
HCC
$3.19B
| $6.28M | 0.01% |
100,000
+75,000
| +300% | +$4.71M |
|
684
Immunic
IMUX
$75.1M
| $6.21M | 0.01% |
5,594,406
| – | – |
|
|
SLRN
685
DELISTED
ACELYRIN
SLRN
| $6.17M | 0.01% |
1,400,000
-1,880,000
| -57% | -$8.29M |
|
686
Clearway Energy Class C
CWEN
$3.38B
| $6.17M | 0.01% |
+250,000
| New | +$6.17M |
|
687
Epsilon Energy
EPSN
$126M
| $6.06M | 0.01% |
1,111,909
| – | – |
|
688
ProQR Therapeutics
PRQR
$258M
| $6.02M | 0.01% |
3,625,467
| – | – |
|
689
Neurogene
NGNE
$285M
| $5.89M | 0.01% |
161,900
-9,745
| -6% | -$355K |
|
690
Teradyne
TER
$19.1B
| $5.89M | 0.01% |
39,724
-35,200
| -47% | -$5.22M |
|
691
Benitec Biopharma
BNTC
$365M
| $5.88M | 0.01% |
841,395
+652,207
| +345% | +$4.56M |
|
692
Sutro Biopharma
STRO
$89.9M
| $5.86M | 0.01% |
2,000,000
| – | – |
|
693
Mohawk Industries
MHK
$8.65B
| $5.78M | 0.01% |
50,870
-1,000
| -2% | -$114K |
|
694
Celcuity
CELC
$2.36B
| $5.74M | 0.01% |
350,317
-307,683
| -47% | -$5.04M |
|
695
Paysafe
PSFE
$864M
| $5.59M | 0.01% |
316,276
-301,725
| -49% | -$5.33M |
|
696
RLJ Lodging Trust
RLJ
$1.18B
| $5.54M | 0.01% |
575,000
-675,000
| -54% | -$6.5M |
|
697
Franklin Resources
BEN
$13B
| $5.53M | 0.01% |
247,600
+91,876
| +59% | +$2.05M |
|
698
Oric Pharmaceuticals
ORIC
$1.06B
| $5.52M | 0.01% |
780,400
-250,000
| -24% | -$1.77M |
|
699
Akamai
AKAM
$11.3B
| $5.5M | 0.01% |
61,100
-11,800
| -16% | -$1.06M |
|
700
Invesco
IVZ
$9.81B
| $5.48M | 0.01% |
366,469
+15,600
| +4% | +$233K |
|